Status:
SUSPENDED
A1c Discordance in Diabetes Patients
Lead Sponsor:
Endocrine Research Society
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
25-70 years
Phase:
NA
Brief Summary
HbA1c is used as a gold standard to see whether patients have optimal glycemic control. Today, many physicians rely solely on HbA1c to change medication. However, there is a select group of patients t...
Eligibility Criteria
Inclusion
- Patient with diabetes
- Patients who test their sugar levels at least 3 times daily
- Recorded diary of sugar levels for the past month
- Willingness to have blood drawn
- Willingness to allow their blood sugar diary to be photocopied
- Estimated average glucose as derived from A1c is ≥ 4 mmol from measured glucose from self-monitoring blood glucose testing
Exclusion
- Patient with medical conditions that may affect their study participation or results will be excluded.
- Patients who are anemic
- Renal insufficient with a serum creatinine level \> 200 μmol/L
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01213277
Start Date
October 1 2010
Last Update
July 26 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.